Conditions/Stomach (Gastric) Cancer/Chapter
Gastric Cancer Treatment
Perioperative chemotherapy plus gastrectomy for many locally advanced tumors; biomarkers guide advanced systemic care.
Treatment is multimodal. Early tumors may proceed to surgery; many locally advanced cancers use perioperative chemotherapy around gastrectomy with appropriate lymphadenectomy. Metastatic disease prioritises systemic therapy guided by biomarkers, with surgery reserved for bleeding, obstruction, or highly selected conversion scenarios. Nutrition support is not optional — it is part of therapy. Staging laparoscopy and cytology, when indicated, can change the plan before major resection.
Figure labels (English)
- Multimodal plan
- Surgery
- Systemic therapy
Who may be a candidate?
- Medically fit patients with localised or locally advanced disease
- Candidates for perioperative regimens after staging laparoscopy when indicated
- Advanced disease needing biomarker-directed systemic therapy
Possible advantages
- Perioperative therapy can shrink tumors and treat micrometastases early
- Modern regimens and supportive care improve completion rates
- Biomarkers open targeted and immunotherapy options in advanced disease
Limits & realistic expectations
- Positive peritoneal cytology / carcinomatosis often removes classic curative sequences
- Malnutrition increases surgical risk if not addressed
- Not every ‘stomach cancer’ shares the same drug pathway
Step-by-step overview
- 1
Define the clinical question
Confirm why gastric cancer treatment is being discussed now — diagnosis, staging, treatment, or surveillance.
- 2
Gather records
Collect imaging, endoscopy, pathology, and prior operative notes before decisions lock.
- 3
Risk-stratify
Match urgency to red flags, labs, and imaging rather than labels alone.
- 4
Choose a pathway
Compare observation, medical therapy, endoscopy, and surgery with expected recovery.
- 5
Plan follow-up
Agree on review timing, warning symptoms, and who to call after hours.
Key points
- How gastric cancer treatment fits the pathwayTap for details
In gastric cancer, “Gastric Cancer Treatment” is a decision node inside a longer journey: symptoms, confirmation, risk stratification, treatment choice, and follow-up. Reading this chapter alongside the hub overview helps you ask better questions in clinic.
- What clinicians weighTap for details
Gastric cancer pathways combine endoscopy, staging laparoscopy when indicated, biomarkers, perioperative therapy, and gastrectomy tailored to location and stage. Your age, comorbidities, prior operations, imaging quality, pathology details, and personal goals can reasonably change the sequence even when the label is the same.
- Disease extent and urgency
- Fitness for anesthesia or procedure
- Alternatives and expected recovery
- Follow-up intensity you can complete
- Warning signs worth urgent reviewTap for details · key note inside
Severe progressive pain, fever with rigidity, vomiting with obstipation, heavy bleeding, sudden breathlessness, or a rapidly worsening wound/stoma problem should not wait for a routine slot. When in doubt, seek urgent assessment and bring prior reports.
- Severe progressive pain
- Fever with peritoneal signs
- Vomiting with inability to pass stool/gas
- Heavy bleeding or collapse
- Practical preparation for your visitTap for details
Bring endoscopy or operative reports, pathology, imaging discs, medication lists, and a short written list of priorities. Ask how this step changes if molecular results, MRI, or second-look findings differ from the preliminary plan.
- Shared decisions and realistic expectationsTap for details
Educational pages cannot replace examination. Two patients with the same gastric cancer treatment label may leave with different plans after staging. Ask what success looks like at three months and one year, and what the rescue plan is if the first pathway fails.
- Technique vs indicationTap for details · key note inside
A named technique is only useful when anatomy and disease biology fit. Conversion to another approach can be a safety decision, not a failure. In the context of gastric cancer, discuss how this point changes timing, alternatives, and follow-up with your surgical team before locking a plan.
- ImportantTap for details · key note inside
Educational information only — not a substitute for clinical evaluation or personalized advice.
Frequently asked questions
- Is surgery always required for gastric cancer?Tap for details
Early selected lesions may have endoscopic options; many localized cancers need gastrectomy with appropriate lymphadenectomy. Metastatic disease prioritizes systemic therapy, with surgery reserved for complications or highly selected conversion scenarios.
- How are options chosen?Tap for details
Extent of disease, symptoms, fitness, and evidence-based alternatives are weighed together — often in a multidisciplinary setting for cancer.
- What should I ask before consent?Tap for details
Benefits, risks, alternatives, expected recovery, and what happens if pathology or imaging changes the plan.
- Can I get a second opinion?Tap for details
Yes. Bring complete imaging and pathology; tumor-board review can be requested when appropriate.
More chapters in this hub
Appointment / info
Educational information only; not a substitute for clinical evaluation.
Medical editor: Assoc. Prof. Cengiz Dibekoğlu, MD · Last medically reviewed: August 2026 · English patient-education chapter.